Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients (Q45178334)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 December 2004
edit
Language Label Description Also known as
English
Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients
scientific article published on 7 December 2004

    Statements

    Long-term therapy with recombinant human erythropoietin increases CD8+ T-cell apoptosis in haemodialysis patients (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit